LY6E and Chagas disease: T. cruzi vaccine antigens Tc24-C4 and TSA1-C4 have been proposed as promising antigens for the development of an immunotherapeutic vaccine to stop or at least delay Chagas disease progression in infected humans8, 36, 37.